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Purpose: To screen the mutation in the retinitis pigmentosa GTPase regulator (RPGR) ORF15 in a large Chinese family
with X-linked recessive retinitis pigmentosa and describe the phenotype in affected male and female carriers.
Methods:  Ophthalmic  examination  was  performed  on  77  family  members  to  identify  affected  individuals  and  to
characterize the disease phenotype. PCR and direct sequencing were used for screening mutations in the RPGR gene.
Results: Mutation screening demonstrated a novel mutation ORF15+577_578 delAG, which caused an open reading
frameshift and resulted in premature truncation of the RPGR protein. The mutation was detected in eight affected male
individuals and 14 obligate female carriers of the family and was found to segregate with the phenotype in this family.
The mutation led to a severe retinitis pigmentosa (RP) phenotype in male-affected individuals, with some variability in
the age of onset of night blindness and visual acuity, but was recessive in female carriers without an RP phenotype.
However, the state associated with the carrier wasPRGHUDWHWRKLJK myopia with the refractive error ranging from −5.00
D to 22.00 D in 14 female carriers.
Conclusions: This novel mutation in RPGR ORF15 causes a serious RP phenotype in males and no RP phenotype in
female carriers. Moderate to high myopia was a particular feature for female carriers in this pedigree. Our finding expands
the spectrum of RPGR mutations causing X-linked RP and expands phenotypic spectrum of the disease in a Chinese
family. This finding will be useful for further genetic consultations and genetic diagnosis.
Retinitis pigmentosa (RP; OMIM 268000) is the most
common form of inherited retinopathy and is characterized by
loss  of  night  vision  in  adolescence,  side  vision  in  young
adulthood,  and  central  vision  in  later  life  because  of  the
progressive degeneration of rod and cone photoreceptor cells.
The prevalence of RP was estimated to be one out of 4,000–
5,000 individuals in Western countries [1] and one out of
3,784  individuals  in  China  [2].  This  disease  affects
approximately 1.5 million individuals worldwide [3].
RP  shows  considerable  clinical  and  genetic
heterogeneity, featuring wide variations in disease severity,
clinical phenotype, age of onset, rate of progression, and mode
of  inheritance,  and  over  40  genes  are  involved.  Despite
intensive research on the pathogenesis of the disease, there is
currently no effective treatment available.
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Inheritance  can  be  autosomal  dominant,  autosomal
recessive, X linked, or in the rare cases taken as a digenic trait.
However,  in  the  majority  of  cases  (about  50%–60%  in
Caucasians)  it  is  impossible  to  establish  the  pattern  of
inheritance, and these cases are defined as “sporadic” [4]. The
X-linked form (XLRP) accounts for 6%–17% of all RP cases,
depending on the countries and the ethnic groups analyzed
[5,6]. XLRP is the most severe type of retinal degeneration
because of its early onset and has the most rapid progression
[7]. Affected individuals experience a decrease in peripheral
and night vision within the first or second decade of life and
show partial or total blindness by the third or fourth decade
[8]. Linkage analysis indicates six different loci have been
clearly associated with the pathogenesis of XLRP, but most
of the XLRP cases (80%–90%) are due to mutations in the RP
guanosine triphosphatase regulator (RPGR; OMIM 312610)
and  the  RP2  (OMIM  312600)  genes  [9].  In  total,
approximately 70%–80% of XLRP cases carry mutations in
RPGR and up to 20% in RP2 [10].
The RPGR gene is located on chromosome Xp21.1 with
23 exons, including the tissue-specific alternatively spliced
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1620exons 9a, open reading frame 15 (ORF15), 15a, and 15b
[11–13]. The N-terminal part of RPGR contains a domain
homologous to the regulator of chromosome condensation 1,
the guanine–nucleotide exchange factor for the guanosine
triphosphatase Ran that is important for the association with
binding partners [14]. Although the RPGR gene has 23 exons,
reports have indicated that pathogenic mutations cluster in
exon  ORF15  [15,16].  These  mutations  include  deletions,
insertions, and substitutions and are associated with a wide
variety  of  human  clinical  phenotypes  [17–23].  It  remains
unknown  how  various  mutations  in  RPGR  can  lead  to
significantly different clinical phenotypes.
The aim of this study was to screen the mutation in a large
Chinese family with a possible XL inheritance pattern and to
characterize the phenotypic manifestation associated with the
mutation.  The  screening  strategy  for  molecular  genetics
testing of XLRP cases is by direct sequencing and beginning
with  the  screening  of  an  XLRP  male  patient  by  ORF15
mutation analysis, as proposed by Neidhardt and coworkers
[14].
METHODS
Study  subjects:  A  family  with  a  possible  XL  inheritance
pattern was recruited at the Department of Ophthalmology in
the People’s Hospital of the Ningxia Hui Autonomous Region
from August 2007 to February 2009. There are 82 family
members in the pedigree, and 77 members were successfully
recruited. There were 41 males and 36 females and the age
ranged from 4.5 to 76 years. All of them were healthy without
other disease except three with hypertension. They received
complete  ophthalmic  examinations,  including  routine
ophthalmic  examinations,  Octopus  perimetry,
electroretinography (ERG), and color fundus photography.
The individuals were diagnosed with nonsyndromic RP if they
had a typical clinical history and features of RP, such as night
blindness,  decreased  visual  fields,  and  bone  spicule
pigmentation on fundus examinations. Syndromic RP, such
as  Usher’s  syndrome,  Leber  congenital  amaurosis,  and
Bardet–Biedl  syndrome,  were  excluded.  Control  subjects
included 80 healthy subjects (42 males and 38 females and the
age ranged from 12 to 70 years) who had undergone detailed
ocular examinations and were confirmed to be free of RP and
other major eye diseases.
Written  informed  consents  were  obtained  from  all
subjects and controls. The study protocol was approved by the
Ethics Committee on Human Research, the People Hospital
of Ningxia Hui Autonomous Region. All procedures in this
study were performed in accordance with the Declaration of
Helsinki.
Mutational screening: Peripheral blood was obtained from 77
family members and 80 normal subjects. The blood were
drawn  with  EDTA  tubes  and  then  stored  at  −20  °C  in
refrigerator for 1 to 7 days before processing. Genomic DNA
was extracted using the QIAamp DNA Blood kit (Qiagen,
Valencia, CA), according to the manufacturer’s instructions.
From the 200 µl input volume of EDTA-whole blood
sample, a final 200 µl extracted volume was obtained. The
steps were as follows: Samples were lysed and heated in the
orbital shaker. Each lysate was transferred to a spin column
in a rotor adaptor and if the lysate needed to be homogenized
or cleared, it was transferred to the middle position of the rotor
adaptor. Nucleic acids were bound to the silica membranes or
purification resins of the spin column and washed to remove
contaminants. The spin column was transferred to a collection
tube for elution of purified nucleic acids. Four pairs of primers
were designed according to the published exon ORF15 of the
RPGR gene sequence from GenBank (OMIM 312610; Table
1). Cycling conditions of the PCR were conducted for 34
cycles as follows: initial denaturation at 95 °C for 5 min,
denaturation at 95 °C for 30 s, annealing at 57.5 °C for 45 s,
elongation at 72 °C for 45 s, and a final single incubation at
72 °C for 5 min. A 5-μl aliquot of PCR product was subjected
to agarose gel electrophoresis on a 2% agarose gel to confirm
successful  amplification  before  sequencing.  The  PCR
products were then used for direct sequencing on a Perkin-
Elmer  3100  Automated  Sequencer  (Applied  Biosystems,
Foster City, CA). The DNA sequences were compared with
the  human  RPGR  (ENSG00000156313)  sequences  in  the
Ensembl database. Detected sequence variants in the DNA
sample  were  confirmed  by  bidirectional  sequencing  on
another stock DNA sample.
RESULTS
There are 82 family members in the pedigree, including five
individuals who have passed away. Eight affected males were
diagnosed by ophthalmic exam. A six-generation pedigree
(with 41 males and 36 females still living) was compiled and
revealed  X-linked  recessive  inheritance  (Figure  1).  Eight
TABLE 1. PRIMER SEQUENCES FOR POLYMERASE CHAIN REACTION RPGR ORF15 SCREENING
Primer
Primer sequence (5′→3′)
PCR product (bp) Forward Reverse
ORF15 1 AGGAAGGAGCAGAGGATTCA CCCTCTTCTTCCATTCTTCC 348
ORF15 2 GGGGAGAAAGACAAGGGTAG TCCTTTCCCCTCCTCTACTT 444
ORF15 3 GGAAGAAGGAGACCAAGGAG CCCATTTCCCTGTGTGTTAG 982
ORF15 4 GCAGGATGGAGAGGAGTACA GAGAGAGGCCAAAATTTACCA 415
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1621affected males and 14 obligate carriers in the six-generation
family were assessed.
Male phenotype: The clinical data of eight affected males
are  summarized  in  Table  2.  All  affected  males  had  mild
myopia with refractive error ranging from −1.50 D to −3.00
D. The proband (V:16) was a 25-year-old man whose night
blindness was noticed at the age of 2 by his mother, after which
the diagnosis of RP was confirmed. He noticed blurred vision
at age 13 but did not visit our hospital for examination until
age 25. Visual acuity was 20/40 on the right eye and 20/60 on
the  left  eye.  Ophthalmologic  examinations  revealed
pigmentation in the mid-peripheral fundi (Figure 2). Octopus
perimetry showed tunnel vision and depression of threshold
values. Both rod and cone electroretinogram amplitudes were
below 10% of normal ERG (Figure 2). The proband’s uncle
(IV:8) had onset in his early 20s, and bilateral legal blindness
was noted in his early 40s. One of the participants (V:1), who
had onset at age 27, was found to have normal central vision
and 20° visual fields at age 33. The two youngest affected
males, a 4.5-year old and an 8-year old (V:30, V:41), were
asymptomatic with mild retinal changes. The other 33 males
without the mutation were hyperopic or low to moderately
myopic  with  the  median  spherical  equivalent  of  –1.75  D
(range, +3.50 D to –3.75 D)
Female phenotype: The clinical data of 14 female carriers
are summarized in Table 3. All female carriers in this pedigree
showed  moderate  to  high  myopia  with  a  refractive  error
ranging from −5.00 D to −22.00 D. The proband’s mother (IV:
Figure 1. Pedigree with six generations. The circles represent females, and the squares represent males; slashed symbols indicate deceased
family members. The filled black symbols denote family members with retinitis pigmentosa, open symbols indicate unaffected individuals,
and circles with a dot indicate female carriers. The arrow marks the index patient (proband).
TABLE 2. SUMMARY OF CLINICAL FINDINGS OF AFFECTED MALES IN THE FAMILY WITH X-LINKED RETINITIS PIGMENTOSA.
Family
member/age
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Abbreviations: AS, asymptomatic; BCVA, best-corrected visual acuity; VF, visual field; ND, not determined; TV, tunnel vision.;
ERG, electroretinography.
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16227), a 56-year-old heterozygous woman, did not have night
blindness. She had high myopia with a best corrected visual
acuity of 20/20 oculus uterque (OU). The fundus examination
showed  chorioretinal  thinning,  myopic  optic  discs,  and
peripapillary  atrophy,  which  were  consistent  with  high
myopia.  No  spicule  formations  were  observed  in  the
peripheral fundi. The ERG showed a normal response.
The proband’s uncle (IV:8), who had severe RP and mild
myopia,  has  three  daughters,  all  of  whom  were
heterozygotous  carriers  (V:17,  V:18,  V:19)  and  exhibited
moderate to high myopia. One daughter, aged 23 wearing
glasses right (R) −18.00 D, left (L) −22.00 D, had 20/30 and
20/60 central vision in both eyes. Deteriorated central visual
acuity was noted at age 9 due to high myopia. A fundus
examination revealed the retinal and optic disc changes that
were consistent with high myopia. No spicule formations were
observed in the peripheral fundi. ERG scotopic amplitudes
were 75% of the normal, and photopic amplitudes were 90%
of the normal. One of her older carrier sisters, wearing glasses
R −15.00 D, L −12.00 D, had 20/50 and 20/40 central vision
(right and left eye, respectively) with the same retinal change
as mentioned above. The other older carrier sister, wearing R
−5.50 D, L −6.75 D, showed normal central vision and a
normal retinal appearance. Among 22 females without the
mutation, 20 had a median of refractive error of –2.50 D
(range, 2.75 D to –4.50 D) and two were found to have high
myopia with a refractive error ranging from −6.25 D to 8.75
D.
Mutational analysis: Among the 77 family members and
80 control subjects, a total of three sequence changes in the
RPGR ORF15 were identified, including one novel deletion
change (Table 4). One variant (N547N) was a synonymous
change, and one (I559V) was a missense change. Both N547N
(rs12687163) and I559V (rs12688514) are common single
nucleotide polymorphisms (SNPs) registered in the dbSNP
database.
A  2-bp  deletion  at  positions  577  and  578  in  exon
ORF15  (Figure  3)  was  identified  in  affected  males  and
obligate female carriers; this deletion is predicted to create an
early termination at codon 248 (Lys192fsTer248). ORF15 Lys
192fsTer248 refers to a frameshift mutation in which Lys 192
is  the  first  amino  acid  altered  and  the  termination  of  the
Figure  2.  Fundus  photographs  and
electroretinography  results  of  the
proband  with  X-linked  retinitis
pigmentosa,.  The  bone  spicule
pigmentation  and  attenuated  retinal
vessels can be seen bilaterally. Both the
rod  and  cone  electroretinogram
amplitudes were below 10% of normal
electroretinography  (ERG;  norms  for
scotopic [skot] ERG: b-wave 27.6 μV
±5.2; norms for photopic [phot] ERG: b-
wave  70  μV±8.9).  Abbreviations:  div
means division.
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1623ORF is at residue 248. The mutation results in a premature
stop  codon  predicted  to  prematurely  truncate  the  RPGR
protein.  The  homozygous  mutation  was  identified  in  all
affected males, and the heterozygous mutation was identified
in all obligate female carriers. The mutation co-segregated
with disease in eight affected males and 14 female carriers in
the family and was not observed in any of the unaffected
family members or the group of normal controls.
DISCUSSION
To date, approximately 70%–80% of XLRP cases are found
to carry mutations in RPGR and up to 20% are found to carry
mutations in RP2 [10]. The exon ORF15, which contains a
purine-rich  domain  of  an  approximately  1706-bp  coding
sequence and is predicted to encode a repetitive glycine and
glutamate region at the C-terminus of the protein, is a mutation
hot spot for XLRP [12]. Between 30% and 80% of RPGR
mutations are identified in exon ORF15, followed by mutation
frequencies that are similar for RP2 and RPGR exons 1–15
[11–13,24–28]. No mutation has yet been identified in exons
16–19. Based on these results and to keep costs low, Neidhardt
and  coworkers  proposed  a  screening  strategy  for  routine
molecular  genetics  testing  of  XLRP  cases  by  direct
sequencing and recommended beginning with the screening
of an XLRP male patient by ORF15 mutation analysis [14].
After identification of an ORF15 mutation, the molecular
diagnosis  is  considered  confirmed  since  patients  with  an
additional  mutation  in  exons  1  through  15  of  RPGR  and
RP2  have  not  been  reported.  If  no  ORF15  mutation  is
identified,  Neidhardt  and  coworkers  recommended  to
continue screening of mutations with RP2 rather than RPGR
because RP2 is composed of only five exons, whereas 15
exons need to be screened to complete the sequence analysis
of RPGR without any clear benefit in terms of likelihood to
detect the causative mutation. Accordingly, we began our
screening on the proband in an X-Linked recessive RP family
by  ORF15  mutation  analysis.  After  an
ORF15+577_578delAG mutation was identified, direct DNA
sequence analysis was performed for all family members and
80 controls. The segregation of the ORF15+577_578delAG
mutation within the family was verified by finding it was only
TABLE 3. SUMMARY OF CLINICAL FINDINGS OF FEMALE CARRIERS IN THE FAMILY WITH X-LINKED RETINITIS PIGMENTOSA.
Family
member/age
(Y) BCVA Optics Fundus VF Rod ERG Cone ERG
III:2/76* 20/100;20/100 −8.50/-8.00 Bilateral myopic fundi NA NA NA
III:4/ 74* 20/80;20/60 -10.25/-9.75 Bilateral myopic fundi NA NA NA
III:5/ 70* 20/60;20/50 −8.75/-6.25 Bilateral myopic fundi NA NA NA
IV: 1/ 57 20/20;20/20 −6.25/-6.50 Normal Full Normal Normal
IV:4/48 20/50;20/60 −6.75/-7.25 Slightly bilateral
Chorioretinal atrophy
Full Normal Normal
IV: 7/ 56 20/20;20/20 −6.75/-6.25 Bilateral myopic fundi Full Normal Normal
IV: 16/ 38 20/25; 20/30 -10.75/-10.25 Bilateral myopic fundi Slightly
reduced
Normal Normal
IV:2 1/ 34 20/20; 20/20 −5.00/-6.25 Slightly bilateral
Chorioretinal atrophy
Full Normal Normal
IV:2 4/ 28 20/20; 20/20 −6.00/-8.25 Normal Full Normal Normal
IV: 22/ 28 20/20; 20/20 −8.00/-8.25 Bilateral myopic fundi Full Normal Normal
V: 17/27 20/50;20/40 −15.00/-12.00 Bilateral myopic fundi Reduced Reduced Reduced
V: 18/25 20/22;20/20 −5.50/-6.75 Normal Full Normal Normal
V: 19/23 20/30;20/60 −18.00/-22.00 Bilateral myopic fundi Reduced Reduced Reduced
V: 36/ 29 20/20; 20/20 -10.0/-9.25 Bilateral myopic fundi Slightly
reduced
Normal Normal
Abbreviations: BCVA, best-corrected visual acuity; VF, visual field; NA, not available; ERG, electroretinography; * cataract
TABLE 4. SEQUENCE VARIATIONS DETECTED IN THE EXON ORF15 OF RPGR GENE AMONG CHINESE RP PATIENTS AND CONTROL SUBJECTS
       
Variation frequency








ORF15 g.ORF15+1677A>G (c.3430A>G) p.I559V
(p.I1144V)
rs12688514 4 6 22 36





Novel 8 14 0 0
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1624present in all affected male individuals and 14 female carriers
of the family but was not present in other normal family
members. In addition, population frequency analysis showed
the  ORF15+577_578delAG  mutation  was  absent  in  80
healthy controls. ORF15+577_578delAG mutation causes an
open reading frameshift, which is predicted to result in a stop
codon at position 248 leading to a premature termination and
to a truncation of 319 amino acids from the protein. Our results
showed  that  the  ORF15+577_578delAG  mutation  was
involved in the RP pathogenesis in this Chinese family. We
confirmed that our approach to amplify the complete exon
ORF15 in a single PCR reduces costs and labor.
To  date,  more  than  100  different  mutations  in  exon
ORF15 have been reported [23,29]; however, the precise role
of ORF15 is still unclear. Studying the genotype–phenotype
correlation can elucidate the expressivity and penetration of
the phenotype in a patient with a specific mutation in RPGR
[20].
Earlier reports have suggested that there is significant
interfamilial  variability  in  the  XLRP  phenotype  [30]  and
different  RPGR  mutations  can  cause  divergent  retinitis
pigmentosa  phenotypes  [22,30].  However,  within  a  given
family the phenotype is usually homogeneous [31,32], but
intrafamilial phenotypic heterogeneity has also been reported
[19,21,33]. In this study we further described this intrafamilial
phenotypic  heterogeneity.  We  showed  that  a  frameshift
mutation  in  ORF15  of  RPGR  causes  a  severe  XLRP
phenotype;  however,  the  male  phenotype  is  distinctly
different. The finding of a single mutation causing different
phenotypes suggests the presence of modifiers, which may be
either genetic, environmental, or both [23].
Historically, most RPGR mutations were considered to
be recessive with clinically normal female carriers or mild
phenotypes [34–38]. However, severely affected carriers have
been  reported  [34,39].  For  RPGR,  the  high  penetrance  in
females seems to be most common with truncating mutations
particularly in exon ORF15 [15,16]. Neidhardt and coworkers
identified  three  pathogenic  sequence  alterations  in  the
mutational hot spot exon ORF15 that also lead to disease
expression in female carriers [14]. The mutation c.2548delG
is found in a family in which the mother, in addition to three
of her sons, is affected [14]. The same mutation occurs in a
second  family  with  reduced  disease  expression  in  female
carriers [14].
ORF15+577_578delAG mutation was not segregated with
high myopia because high myopia was also observed in two
female family members without the mutation. Therefore, the
findings of  our  study do  necessarily  signify  that  moderate
Figure 3. Results of nucleotide sequencing analysis. A: Family has
a ORF15+577_578delAG mutation. The upper sequences (A) are the
normal alleles. The middle sequences (B) are homozygous mutation
identified  in  affected  male  and  the  lower  sequences  (C)  are
heterozygous  mutation  identified  in  obligate  female.  The  black
rectangles indicate the deleted two nucleotides. The filled squares
indicate  homozygous  condition  of  the  base.  The  partially  filled
squares indicate heterogeneous condition of the base.
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What is intriguing is the fact that the truncating mutation
in  the  exon  ORF15  identified  here  causes  a  serious  RP
phenotype in males and no RP phenotype in heterozygote
female carriers. All affected males exhibited RP but all female
carriers were recessive with RP in the same family with the
same  mutation.  The  state  associated  with  the  carrier  was
moderate to high myopia with a refractive error ranging from
−5.00  D  to  22.00  D  in  14  female  carriers.  However,  theto high myopia is more prevalent in females in this family with
an ORF15+577_578delAG mutation, and it is conceivable
that high myopia is also a variable expression of this RPGR
mutation. Other studies have found high myopia in patients
with XLRP, particularly in females with RPGR mutations.
Yang  and  coworkers  identified  a  GA  deletion  at
ORF15+483_484delGA of RPGR in a family with XLRP in
which all female patients had a refractive error of −6 D or more
[23].  Koenekoop  and  coworkers  identified  two  RPGR
mutations in two families with XLRP [19]. A Glu 414 (2-bp
deletion)  frameshift  mutation  was  found  in  nine  affected
males and six affected females in family I in which all affected
females had myopia with a refractive error ranging from −2
D  to  −9  D  and  all  affected  males  were  emmetropic.  An
intervening sequence (IVS) 2–1 (G to A) splice site mutation
occurred in one affected male and two affected females in
family II in which all affected individuals had high myopia
with a refractive error ranging from −7 D to −10 D. Jin and
coworkers identified a mutation, ORF15+1232_ 1233delGG,
in a family with XLRP. Among six recruited individuals, two
affected  females  had  high  myopia  with  a  refractive  error
ranging from −14.50 D to 18.50 D, two affected males had
low to moderate myopia with a refractive error ranging from
−1.000 D to 5.00 D, and two unaffected individuals were
emmetropic [20].
Among the RPGR ORF15 sequence variants detected in
our  Chinese  subjects,  the  two  previously  reported
(rs12687163 and rs12688514) SNPs were found not only in
patients  but  also  in  normal  family  members  and  control
individuals  and  could  be  excluded  as  disease-causing
mutations.
In  conclusion,  we  identified  a  novel  mutation,
ORF15+577_578delAG, in the RPGR gene in a large Chinese
family  with  X-linked  recessive  retinitis  pigmentosa  and
documented the clinical manifestations. Our review of the
phenotypes  by  genotype  analysis  showed  that  there  is
significant intrafamilial variability in the XLRP phenotype.
Moderate to high myopia is a particular feature for female
carriers in this pedigree. This feature may be the most reliable
guide  to  the  female  carrier  status  in  XLRP,  its  presence
implying a mutation in the RPGR gene. Our finding expands
the  spectrum  of  RPGR  mutations  causing  XLRP  and  the
phenotypic spectrum of the disease in a Chinese family, and
will be useful for additional genetic consultation and genetic
diagnosis.  Further  investigations  will  identify  and
characterize the possible genetic modifiers that determine the
clinical outcome of RPGR mutations in female carriers.
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